CTRI/2023/10/058545进行中（未招募）Unknown
A randomized, double blind, two arm, comparative, parallel, in-use tolerability, safety and efficacy study of Hair Growth and Anti-Gray Hair Oil in healthy adult females with partially gray hairs and hair fall complaints. - NI
Keva – S H Kelkar and Company Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Age: 20 to 55 years (both inclusive) at the time of consent.
- •2) Sex: Healthy non-pregnant/non-lactating females.
- •3) Females of childbearing potential must have a self-reported negative pregnancy test.
- •4) Subject are generally in good health.
- •5) Subject with partially gray hair.
- •6) Subject with low hair growth and complaint of hair fall.
- •7) Subject with self-assessed complaint of thinning of hair.
- •8) Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study.
- •9) If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation.
- •10) If currently using hormonal contraception, has been using this form of contraception for at least 6 months and agrees to continue using the same contraception for the duration of the study.
- •11) Subjects are willing to give written informed consent and are willing to follow the study procedure.
- •12) Subjects who commit not to use medicated/ prescription shampoos/hair care products (containing Minoxidil), any other hair growth hair products or hair colour or dye, other than the test products for the entire duration of the study.
- •13) Willing to use test product throughout the study period.
排除标准
- •1) Subjects with any other hair colour except gray.
- •2) History of any dermatological condition of the scalp other than hair loss and/or dandruff.
- •3) History of prior use of hair growth treatment within 3 months.
- •4) History of any prior hair growth procedures (e.g., hair transplant or laser).
- •5) Subjects who have applied topical treatment for hair loss for at least 4 weeks and any systemic treatment for at least 3 months, before they participated in the study.
- •6) History of alcohol or drug addiction.
- •7) Subjects using other marketed hair fall control and/or hair growth products during the study period.
- •8) Subjects who have plans of shaving scalp hair during the study.
- •9) Subjects who are on chronic oral steroids 03 months before initial application and during the study period.
- •10) History or present condition of irritated or visibly inflamed scalp or severe scalp disease.
- •11) Subjects having a history or present condition of an allergic response to any cosmetic products.
- •12) Any other condition which could warrant exclusion from the study, as per the dermatologist’s/investigator’s discretion.
- •13) Pregnant or breastfeeding or planning to become pregnant during the study period.
- •14) History of chronic illness which may influence the cutaneous state.
- •15) Subjects participating in other similar cosmetics, devices or therapeutic trials or hair/scalp care products within the last four weeks
研究者
相似试验
招募中
Unknown
A clinical study to assess the safety and effectiveness of two different anti-stretchmark creams in healthy human subjects with complaints of stretchmarks from weight loss or post-pregnancy.CTRI/2023/09/057526Anveya Living Private Limited
已完成
3 期
A Clinical trial to check the effect, Safety and Tolerability of Ripasudil Hydrochloride Hydrate Eye Drops 0.4% w/v Vs Timolol Maleate Eye Drops 0.5% w/v in patients with Ocular Hypertension / GlaucomaCTRI/2018/04/013091Ajanta Pharma Ltd217
已完成
3 期
A study of Netarsudil Ophthalmic Solution 0.02% w/v Vs Timolol Maleate Eye Drops 0.5% w/v in treatment of elevated intraocular pressure in patient with open angle glaucoma or ocular hypertension.CTRI/2020/01/022619Ajanta Pharma Ltd197
已完成
3 期
A Clinical Study to Evaluate Efficacy, Safety and Tolerability of Iguratimod Tablets Vs. Methotrexate Tablets for the treatment of Active Rheumatoid Arthritis.CTRI/2017/07/009079Ajanta Pharma Ltd244
已完成
2 期
Comparative Study to assess efficacy and safety of Mycobacterium W. in Combination with Standard Therapy versus Standard Therapy Alone in treatment of Sepsis.CTRI/2015/07/005961Cadila Pharmaceuticals Limited202